PRTK Annual CAPEX
$36.00 K
-$337.00 K-90.35%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual capital expenditures is $36.00 thousand, with the most recent change of -$337.00 thousand (-90.35%) on December 31, 2022. During the last 3 years, it has fallen by -$203.00 thousand (-84.94%).PRTK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly CAPEX
$0.00
-$32.00 K-100.00%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly capital expenditures is $0.00, with the most recent change of -$32.00 thousand (-100.00%) on June 30, 2023. Over the past year, it has stayed the same.PRTK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM CAPEX
$32.00 K
$0.000.00%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM capital expenditures is $32.00 thousand, unchanged on June 30, 2023. Over the past year, it has increased by +$2000.00 (+6.67%).PRTK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.3% | 0.0% | +6.7% |
| 3 y3 years | -84.9% | -100.0% | -93.8% |
| 5 y5 years | -96.8% | -100.0% | -86.6% |
PRTK CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -96.8% | -100.0% | -99.7% |
Paratek Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $0.00(-100.0%) | $32.00 K(0.0%) |
| Mar 2023 | - | $32.00 K(>+9900.0%) | $32.00 K(-11.1%) |
| Dec 2022 | $36.00 K(-90.3%) | $0.00(0.0%) | $36.00 K(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $36.00 K(+20.0%) |
| June 2022 | - | $0.00(-100.0%) | $30.00 K(-79.6%) |
| Mar 2022 | - | $36.00 K(>+9900.0%) | $147.00 K(-60.6%) |
| Dec 2021 | $373.00 K(-0.8%) | $0.00(-100.0%) | $373.00 K(-10.8%) |
| Sept 2021 | - | -$6000.00(-105.1%) | $418.00 K(-9.9%) |
| June 2021 | - | $117.00 K(-55.3%) | $464.00 K(+20.5%) |
| Mar 2021 | - | $262.00 K(+482.2%) | $385.00 K(+2.4%) |
| Dec 2020 | $376.00 K(+57.3%) | $45.00 K(+12.5%) | $376.00 K(-28.4%) |
| Sept 2020 | - | $40.00 K(+5.3%) | $525.00 K(+1.2%) |
| June 2020 | - | $38.00 K(-85.0%) | $519.00 K(+7.9%) |
| Mar 2020 | - | $253.00 K(+30.4%) | $481.00 K(+101.3%) |
| Dec 2019 | $239.00 K(+298.3%) | $194.00 K(+470.6%) | $239.00 K(+368.6%) |
| Sept 2019 | - | $34.00 K(>+9900.0%) | $51.00 K(+200.0%) |
| June 2019 | - | $0.00(-100.0%) | $17.00 K(-63.8%) |
| Mar 2019 | - | $11.00 K(+83.3%) | $47.00 K(-21.7%) |
| Dec 2018 | $60.00 K(-94.6%) | $6000.00(>+9900.0%) | $60.00 K(+900.0%) |
| Sept 2018 | - | $0.00(-100.0%) | $6000.00(-86.0%) |
| June 2018 | - | $30.00 K(+25.0%) | $43.00 K(-82.4%) |
| Mar 2018 | - | $24.00 K(-150.0%) | $244.00 K(-78.2%) |
| Dec 2017 | $1.12 M(+61.9%) | -$48.00 K(-229.7%) | $1.12 M(-27.5%) |
| Sept 2017 | - | $37.00 K(-84.0%) | $1.54 M(+6.7%) |
| June 2017 | - | $231.00 K(-74.2%) | $1.44 M(-3.0%) |
| Mar 2017 | - | $897.00 K(+138.6%) | $1.49 M(+115.7%) |
| Dec 2016 | $690.00 K(-19.4%) | $376.00 K(-726.7%) | $690.00 K(+42.6%) |
| Sept 2016 | - | -$60.00 K(-121.8%) | $484.00 K(-39.4%) |
| June 2016 | - | $275.00 K(+177.8%) | $799.00 K(-2.4%) |
| Mar 2016 | - | $99.00 K(-41.8%) | $819.00 K(-4.3%) |
| Dec 2015 | $856.00 K | $170.00 K(-33.3%) | $856.00 K(+24.8%) |
| Sept 2015 | - | $255.00 K(-13.6%) | $686.00 K(+59.2%) |
| June 2015 | - | $295.00 K(+116.9%) | $431.00 K(+216.9%) |
| Mar 2015 | - | $136.00 K(-1233.3%) | $136.00 K(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | - | -$12.00 K(-220.0%) | $0.00(-100.0%) |
| Sept 2013 | - | $10.00 K(>+9900.0%) | $21.00 K(-36.4%) |
| June 2013 | - | $0.00(-100.0%) | $33.00 K(-23.3%) |
| Mar 2013 | - | $2000.00(-77.8%) | $43.00 K(0.0%) |
| Dec 2012 | $43.00 K(-27.1%) | $9000.00(-59.1%) | $43.00 K(-15.7%) |
| Sept 2012 | - | $22.00 K(+120.0%) | $51.00 K(+64.5%) |
| June 2012 | - | $10.00 K(+400.0%) | $31.00 K(-38.0%) |
| Mar 2012 | - | $2000.00(-88.2%) | $50.00 K(-15.3%) |
| Dec 2011 | $59.00 K(-9.2%) | $17.00 K(+750.0%) | $59.00 K(-9.2%) |
| Sept 2011 | - | $2000.00(-93.1%) | $65.00 K(-12.2%) |
| June 2011 | - | $29.00 K(+163.6%) | $74.00 K(0.0%) |
| Mar 2011 | - | $11.00 K(-52.2%) | $74.00 K(+13.8%) |
| Dec 2010 | $65.00 K(-79.6%) | $23.00 K(+109.1%) | $65.00 K(+1.6%) |
| Sept 2010 | - | $11.00 K(-62.1%) | $64.00 K(-43.4%) |
| June 2010 | - | $29.00 K(+1350.0%) | $113.00 K(-32.7%) |
| Mar 2010 | - | $2000.00(-90.9%) | $168.00 K(-47.2%) |
| Dec 2009 | $318.00 K(+22.8%) | $22.00 K(-63.3%) | $318.00 K(-40.1%) |
| Sept 2009 | - | $60.00 K(-28.6%) | $531.00 K(+12.7%) |
| June 2009 | - | $84.00 K(-44.7%) | $471.00 K(+21.7%) |
| Mar 2009 | - | $152.00 K(-35.3%) | $387.00 K(+49.4%) |
| Dec 2008 | $259.00 K(-76.4%) | $235.00 K(>+9900.0%) | $259.00 K(-55.0%) |
| Sept 2008 | - | $0.00(0.0%) | $575.00 K(-47.2%) |
| June 2008 | - | $0.00(-100.0%) | $1.09 M(-110.0%) |
| Mar 2008 | - | $24.00 K(-95.6%) | -$10.90 M(-1092.0%) |
| Dec 2007 | $1.10 M(+5684.2%) | $551.00 K(+7.2%) | $1.10 M(+100.2%) |
| Sept 2007 | - | $514.00 K(-104.3%) | $549.00 K(+1272.5%) |
| June 2007 | - | -$11.99 M(-199.7%) | $40.00 K(-99.7%) |
| Mar 2007 | - | $12.03 M(>+9900.0%) | $12.04 M(>+9900.0%) |
| Dec 2006 | $19.00 K(-87.7%) | $1000.00(-80.0%) | $19.00 K(+5.6%) |
| Sept 2006 | - | $5000.00(-54.5%) | $18.00 K(+38.5%) |
| June 2006 | - | $11.00 K(+450.0%) | $13.00 K(+550.0%) |
| Mar 2006 | - | $2000.00 | $2000.00 |
| Dec 2005 | $154.00 K(+10.0%) | - | - |
| Dec 2004 | $140.00 K | - | - |
FAQ
- What is Paratek Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual CAPEX year-on-year change?
- What is Paratek Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Paratek Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM CAPEX year-on-year change?
What is Paratek Pharmaceuticals annual capital expenditures?
The current annual CAPEX of PRTK is $36.00 K
What is the all time high annual CAPEX for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual capital expenditures is $1.12 M
What is Paratek Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, PRTK annual capital expenditures has changed by -$337.00 K (-90.35%)
What is Paratek Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of PRTK is $0.00
What is the all time high quarterly CAPEX for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly capital expenditures is $12.03 M
What is Paratek Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, PRTK quarterly capital expenditures has changed by $0.00 (0.00%)
What is Paratek Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of PRTK is $32.00 K
What is the all time high TTM CAPEX for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM capital expenditures is $12.04 M
What is Paratek Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, PRTK TTM capital expenditures has changed by +$2000.00 (+6.67%)